Literature DB >> 7804252

In vivo efficacy of albendazole against Encephalitozoon cuniculi in SCID mice.

B Koudela1, J Lom, J Vítovec, Z Kucerová, O Ditrich, J Trávnícek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7804252

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


× No keyword cloud information.
  7 in total

1.  Pure CD4+ T lymphocytes fail to protect perorally infected SCID mice from lethal microsporidiosis caused by Encephalitozoon cuniculi.

Authors:  Jirí Salát; Helena Horká; Bohumil Sak; Jan Kopecký
Journal:  Parasitol Res       Date:  2006-11       Impact factor: 2.289

Review 2.  Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.

Authors:  C Franzen; A Müller
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

3.  Chronic Infections in Mammals Due to Microsporidia.

Authors:  Bohumil Sak; Martin Kváč
Journal:  Exp Suppl       Date:  2022

4.  Encephalitozoon cuniculi Genotype II Concentrates in Inflammation Foci.

Authors:  Klára Brdíčková; Bohumil Sak; Nikola Holubová; Dana Květoňová; Lenka Hlásková; Marta Kicia; Żaneta Kopacz; Martin Kváč
Journal:  J Inflamm Res       Date:  2020-09-25

5.  Efficacy of gamma interferon and specific antibody for treatment of microsporidiosis caused by Encephalitozoon cuniculi in SCID mice.

Authors:  Jirí Salát; Jirí Jelínek; Jindrich Chmelar; Jan Kopecky
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

6.  Effects of a novel anti-exospore monoclonal antibody on microsporidial development in vitro.

Authors:  B Sak; K Saková; O Ditrich
Journal:  Parasitol Res       Date:  2003-11-11       Impact factor: 2.289

7.  Latent microsporidiosis caused by Encephalitozoon cuniculi in immunocompetent hosts: a murine model demonstrating the ineffectiveness of the immune system and treatment with albendazole.

Authors:  Michaela Kotkova; Bohumil Sak; Dana Kvetonova; Martin Kvac
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.